Axendia just turned 21, and we’re stepping into this milestone with purpose, momentum, gratitude, and the same forward leaning conviction that has defined us since […]
Axendia Turns 21: A Toast to Your Trust and the Road Ahead Read More »
Axendia’s Analysis of the Root Causes and Our Recommendations to Prevent Them There has been a lot of buzz around FDA’s warning letter which for
FDA Calls Out Inappropriate Use of Artificial Intelligence Read More »
AI is transforming Life Sciences. It is moving from generating insights to coordinating workflows and making decisions that support quality, safety, and innovation. We want
Industry Webinar Recap The MedTech industry stands at a historic inflection point. Economic volatility, rising regulatory demands, and transformative technology advances are challenging traditional business
Future-Ready MedTech: Capitalizing on Trends to Fuel Growth Read More »
The U.S. Food and Drug Administration has just made it official: your excuses for clinging to outdated systems because of antiquated validation practices are gone.
FDA CSA Just Removed Your Excuses for Implementing Modern Technology Read More »
In 2005, Axendia was founded to meet a critical need: trusted, strategic, and actionable advice from experts who truly understand the intricate balance of business,
Axendia at 20: Forging the Future of Life Sciences! Read More »
Veeva Briefing Note Veeva’s Mike Jovanis, President, Quality Cloud, Jamie Crouch, VP Marketing, Quality Cloud, and Ashley McMillan, Senior Director, Veeva LIMS Strategy, provided an in-depth update on their continued progress
Veeva Expands Its Vision for Quality and Manufacturing Read More »
What you need to know about the Bipartisan MAPS Act In the age of continuous disruption, from pandemics to geopolitical conflicts and trade uncertainty, the
Congress Wants to Map the Pharmaceutical Supply Chain Read More »
EQTY Lab Briefing Note Axendia was briefed by the executive team at EQTY Lab, including Dr. Tina Dr. Morrison, VP Scientific Strategy and Alistair Dootson, Head of Life
Driving AI Integrity in Life Sciences Read More »
FDA Expects That Records be Submitted in Electronic Format Nestled within FDA’s final guidance on Remote Regulatory Assessments (RRAs) is a pivotal and decisive statement:
Why Paper Won’t Cut It In FDA’s Remote Oversight Era Read More »
On May 5, 2025, an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines“ was signed by the administration. The order seeks
Strengthening Domestic Pharmaceutical Manufacturing in the Age of Continuous Disruption Read More »
From Simple Prompts to Autonomous Systems Artificial intelligence is driving a significant transformation in quality management. Quality management is evolving from basic command-based interactions into
The Evolution of AI in Quality Management Read More »
